Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

National Institute of Environmental Health Sciences

Use this QR code to view the newest version of this document
Use this QR code to view the newest version of this document

Your Environment. Your Health.

Publication Detail

Title: P38 MAPK mediates COX-2 gene expression by corticosterone in cardiomyocytes.

Authors: Sun, Haipeng; Xu, Beibei; Inoue, Hiroyasu; Chen, Qin M

Published In Cell Signal, (2008 Nov)

Abstract: Recent work from our laboratory found that corticosteroids induce transcriptional activation of cyclooxygenase-2 (COX-2) gene in cardiomyocytes. Here we report that COX-2 gene promoter mutation studies indicate a role of cAMP response element-binding protein (CREB) in corticosterone-induced COX-2 gene expression. Corticosterone causes activation of p38 MAPK and subsequent CREB phosphorylation at serine 133 in cardiomyocytes. The inhibitors of p38 MAPK, SB202190 and SB203580, block corticosterone from inducing CREB phosphorylation and COX-2 gene expression while dominant-negative p38 MAPK or CREB prevents corticosterone from activating COX-2 promoter. Corticosterone does not induce p38 MAPK activation or COX2 expression in cardiac fibroblasts or HEK293 cells transfected with glucocorticoid receptor, suggesting that p38 MAPK activation is cell specific and necessary for corticosterone-induced COX-2 expression in cardiomyocytes. While glucocorticoid receptor antagonist mifepristone inhibits COX-2 gene induction by corticosterone, mifepristone fails to inhibit p38 MAPK activation or CREB phosphorylation. In contrast, inhibition of p38 MAPK does not prevent corticosterone from activating glucocorticoid receptor. Our data suggest that two parallel signaling pathways, glucocorticoid receptor and p38 MAPK, act in concert to regulate the expression of COX-2 gene in cardiomyocytes.

PubMed ID: 18657608 Exiting the NIEHS site

MeSH Terms: Animals; Corticosterone/pharmacology*; Cyclic AMP Response Element-Binding Protein/metabolism; Cyclooxygenase 2/genetics*; Cyclooxygenase 2/metabolism; Enzyme Activation/drug effects; Fibroblasts/drug effects; Fibroblasts/enzymology; Gene Expression Regulation, Enzymologic/drug effects*; MAP Kinase Signaling System/drug effects; Mifepristone/pharmacology; Myocytes, Cardiac/drug effects*; Myocytes, Cardiac/enzymology*; Phosphorylation/drug effects; Promoter Regions, Genetic; Protein Kinase Inhibitors/pharmacology; RNA, Messenger/genetics; RNA, Messenger/metabolism; Rats; Receptors, Glucocorticoid/metabolism; p38 Mitogen-Activated Protein Kinases/metabolism*

Back
to Top